Benefits of BPC 157: Oral vs Subcutaneous Administration Master IM Injections: 5 Key Techniques for Optimal Results BPC 157 American Wellness Pharmacy BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Amazon.com: Ambimedinc Inject Ease Automatic Syringe Injector for Subcutaneous Injections or Needle Depths of 1 2" or Less Using a 1ml, 1 2ml, or 1 3ml Insulin Syringe with a Fixed Tip Needle : Health & Household